Aggressive tPA stroke treatment promises lower long-term costs
The FDA approved use of tissue plasminogen activator (tPA) for stroke in 1996, but it took another 10 years for the Centers for Medicare and Medicaid Services to offer reimbursement. The agency's decision is part of a larger trend that recognizes the value of preventive care and treatment compared with the cost of longer hospital stays.
The FDA approved use of tissue plasminogen activator (tPA) for stroke in 1996, but it took another 10 years for the Centers for Medicare and Medicaid Services to offer reimbursement. The agency's decision is part of a larger trend that recognizes the value of preventive care and treatment compared with the cost of longer hospital stays.
"The idea of spending a lot of resources up front on stroke patients is gaining momentum. The fact that CMS recently raised the payment amount for acute stroke is recognition from the government that the acute care setting is a small fraction of the true costs of stroke management.
"If you spend more money on stroke patients in the first two days in the hospital, you can save money in the long run because the patients get better. Studies have shown that inpatient costs are about 3% of the overall costs of a stroke. If you double that amount and if you also reduce bad outcomes by 5%, you've more than paid for yourself, not to mention you have 5% more people with better outcomes."
-Dr. A. Greg Sorensen, a staff neuroradiologist at Massachusetts General Hospital and director of its Center for Biomarkers in Imaging.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
